Front-line immunosuppressive treatment of acquired aplastic anemia
- 19 November 2012
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 48 (2) , 174-177
Abstract
In this article, front-line immunosuppressive therapy (IST) for acquired plastic anemia (AA) is illustrated and discussed. Also second-line and salvage options are briefly illustrated. First-line IST should consist of horse anti-thymocyte globulin (ATG) and CsA that has been shown to result in response rates between 60 and 80%. CsA should be given for 12 months until transfusion independence is achieved and then tapered very slowly in the presence of a CR. Patients with a partial response are usually continued on CsA. Tight monitoring of the blood count during CsA tapering is necessary to identify early loss of response. G-CSF 5 μg/kg/day s.c. in the first 30 days has been shown to reduce infections and hospitalization and to identify early responders, as those who achieve neutrophils count of0.5 × 10(9)/L by day +30. This schedule is recommended in the first month of therapy. Afterward, G-CSF can be considered in neutropenic febrile episodes. Patients not achieving transfusion independence after a first course of IST may be considered for second-line IST, or for an allogeneic hematopoietic SCT depending on patient age, ongoing infection, neutrophil count and transfusion requirements. Third-line IST is rarely given, but some options are discussed.Keywords
This publication has 23 references indexed in Scilit:
- Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working PartyBlood, 2012
- Long-Term Outcome of Immunosuppressive Therapy with Rabbit Antithymocyte Globulin (rATG) for Childhood Severe Aplastic Anemia for 15 YearsBlood, 2011
- Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic AnemiaBlood, 2011
- Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic AnemiaNew England Journal of Medicine, 2011
- Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemiaHaematologica, 2011
- Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective studyAnnals of Hematology, 2010
- Guidelines for the diagnosis and management of aplastic anaemiaBritish Journal of Haematology, 2009
- Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long‐term observation follow‐upBritish Journal of Haematology, 2007
- Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow TransplantationHaematologica, 2007
- Rabbit antithymocyte globulin (r‐ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapyBritish Journal of Haematology, 1999